Related Experiment Video
Updated: Sep 5, 2025
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines
Omar Perbellini1, Chiara Cavallini2, Roberto Chignola3
1Department of Cell Therapy and Hematology, San Bortolo Hospital, Viale Ferdinando Rodolfi, 37, 36100 Vicenza, Italy.
Abstract:
Several signaling pathways are aberrantly activated in T-ALL due to genetic alterations of their components and in response to external microenvironmental cues. To functionally characterize elements of the signaling network in T-ALL, here we analyzed ten signaling proteins that are frequently altered in T-ALL -namely Akt, Erk1/2, JNK, Lck, NF-κB p65, p38, STAT3, STAT5, ZAP70, Rb- in Jurkat, CEM and MOLT4 cell lines, using phospho-specific flow cytometry. Phosphorylation statuses of signaling proteins were measured in the basal condition or under modulation with H2O2, PMA, CXCL12 or IL7. Signaling profiles are characterized by a high variability across the analyzed T-ALL cell lines. Hierarchical clustering analysis documents that higher intrinsic phosphorylation of Erk1/2, Lck, ZAP70, and Akt, together with ZAP70 phosphorylation induced by H2O2, identifies Jurkat cells. In contrast, CEM are characterized by higher intrinsic phosphorylation of JNK and Rb and higher responsiveness of Akt to external stimuli. MOLT4 cells are characterized by higher basal STAT3 phosphorylation. These data document that phospho-specific flow cytometry reveals a high variability in intrinsic as well as modulated signaling networks across different T-ALL cell lines. Characterizing signaling network profiles across individual leukemia could provide the basis to identify molecular targets for personalized T-ALL therapy.
Insights
Signaling pathway analysis in T-cell acute lymphoblastic leukemia (T-ALL) cell lines reveals significant variability. Understanding these distinct signaling profiles is key to developing personalized therapies for T-ALL.
Area of Science:
- Oncology
- Cellular Biology
- Immunology
Background:
- Signaling pathways are crucial in T-cell acute lymphoblastic leukemia (T-ALL) development, influenced by genetic changes and microenvironment.
- Aberrant activation of signaling networks contributes to T-ALL pathogenesis.
Purpose of the Study:
- To functionally characterize signaling network elements in T-ALL.
- To investigate signaling protein phosphorylation in different T-ALL cell lines under various conditions.
Main Methods:
- Analyzed ten key signaling proteins (Akt, Erk1/2, JNK, Lck, NF-κB p65, p38, STAT3, STAT5, ZAP70, Rb) in Jurkat, CEM, and MOLT4 T-ALL cell lines.
- Utilized phospho-specific flow cytometry to measure protein phosphorylation.
- Assessed basal and modulated signaling in response to H₂O₂, PMA, CXCL12, and IL7.
Main Results:
- Demonstrated high variability in intrinsic and modulated signaling profiles across T-ALL cell lines.
- Identified distinct signaling signatures for Jurkat (high Erk1/2, Lck, ZAP70, Akt phosphorylation), CEM (high JNK, Rb phosphorylation; responsive Akt), and MOLT4 (high basal STAT3 phosphorylation) cells.
- Showcased phospho-specific flow cytometry's ability to reveal complex signaling network differences.
Conclusions:
- Phospho-specific flow cytometry effectively differentiates T-ALL cell lines based on their signaling network characteristics.
- Intrinsic and modulated signaling profiles vary significantly among T-ALL subtypes.
- Characterizing individual leukemia signaling networks can guide the identification of targeted therapies for personalized T-ALL treatment.
More Related Videos
08:38Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
Published on: October 4, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
